Cargando…
Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?
Malignant hyperpyrexia syndrome (MHS) is a rare entity and may not be encountered by the anaesthesiologists throughout their professional career. Whenever it manifests can be a challenging task to manage and prove to be fatal when a timely diagnosis and required therapeutic measures are not taken. A...
Autores principales: | Gupta, Priyanka, Kamal, Geeta, Gupta, Mayank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714388/ https://www.ncbi.nlm.nih.gov/pubmed/26816473 http://dx.doi.org/10.4103/0976-500X.171873 |
Ejemplares similares
-
UTILITY OF DANTROLENE FOR HYPERPYREXIA IN THE MANAGEMENT SARS-COV-2 INFECTION
por: LEYS, LORENZO, et al.
Publicado: (2021) -
Malignant hyperthermia when dantrolene is not readily available
por: Gong, Xiaodan
Publicado: (2021) -
Postoperative hyperpyrexia: Retracing malignant hyperthermia
por: Gupta, Devendra, et al.
Publicado: (2012) -
Malignant hyperthermia and dantrolene sodium
por: Kim, Ha Jung, et al.
Publicado: (2019) -
Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
por: McCoy, E. P., et al.
Publicado: (1994)